Investors Capital Advisory Services’s Novavax NVAX Stock Holding History

Investors Capital Advisory Services’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-673	Closed	-$56K	–	740
2014 Q3	$56K	Sell	673 -105	-13%	-$9.49K	0.01%	664
2014 Q2	$71K	Buy	+778	New	+$68.4K	0.01%	667
2014 Q1	–	Sell	-543	Closed	-$55K	–	691
2013 Q4	$55K	Sell	543 -262	-33%	-$18.5K	0.01%	609
2013 Q3	$50K	Sell	805 -293	-27%	-$16.5K	0.01%	571
2013 Q2	$44K	Buy	+1,098	New	+$47.6K	0.01%	528

Other funds holding NVAX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Investors Capital Advisory Services's NVAX Position: Q4 2014 in Review

Investors Capital Advisory Services sold out of Novavax (NVAX) in Q4 2014, closing a stake of 673 shares — an estimated $56K sold.

Investors Capital Advisory Services first reported a position in NVAX in Q2 2013 and held it in 5 quarters. The position peaked at $71K in Q2 2014. 153 funds tracked by Wall St. Rank hold NVAX as of Q4 2014.

Investors Capital Advisory Services reported no remaining Novavax position as of Q4 2014 after selling out during the quarter.
Investors Capital Advisory Services sold 673 Novavax shares in Q4 2014, an estimated $56K.
Investors Capital Advisory Services first reported a position in Novavax in Q2 2013 and held it in 5 quarters.
Investors Capital Advisory Services's Novavax position peaked at $71K in Q2 2014.
153 funds tracked by Wall St. Rank held Novavax as of Q4 2014.

Based on Investors Capital Advisory Services's 13F filing for Q4 2014, filed 3 Feb 2015.